Atorvastatin Calcium Tablet
Product Images NDC 43598-832

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 43598-832). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Packaging label for Atorvastatin Calcium Tablets, USP 10 mg by Dr. Reddy's Laboratories Inc. The label specifies 100 tablets (10 x 10 unit-dose) with Rx only. Distributor address is Princeton, NJ, and the product is made in India. The design features blue and pink text with a Dr. Reddy's logo.*

FDA Label Image

Carton2 (Carton2)

Packaging label for Atorvastatin Calcium Tablets, USP 20 mg by Dr. Reddy's Laboratories Inc. The label indicates 100 tablets (10 x 10 unit-dose) for institutional use, Rx only, made in India. The label includes dosage instructions, storage conditions, and a barcode.*

FDA Label Image

Carton3 (Carton3)

Packaging label for Atorvastatin Calcium Tablets USP 40 mg by Dr. Reddy's Laboratories Inc. The carton contains 100 tablets in 10 unit-dose cards. The label indicates prescription use only, with distributor information showing Dr. Reddy's Laboratories Inc., Princeton, NJ, and that the product is made in India. The design includes the product name and strength prominently with the Dr. Reddy's logo.*

FDA Label Image

Carton4 (Carton4)

Atorvastatin Calcium Tablets, USP 80 mg carton packaging for oral tablets. The box contains 30 tablets (3 x 10 unit-dose) and is labeled for institutional use only. Distributed by Dr. Reddy's Laboratories Inc., Princeton, NJ, made in India. The label includes dosage strength, product name, and NDC 43598-833-81.*

FDA Label Image

Container1 (Container1)

Label for Atorvastatin Calcium Tablets, USP 10 mg oral tablets by Dr. Reddy's Laboratories Inc. The label indicates 90 coated tablets per bottle, with dosage and storage instructions. A barcode and QR code for patient information are also visible. The label is primarily white with blue and pink text.*

FDA Label Image

Container2 (Container2)

Label for Atorvastatin Calcium Tablets USP 20 mg oral tablets by Dr. Reddy's Laboratories Inc. The label indicates a package containing 90 tablets with storage and dispensing instructions. A QR code for patient information is also present along with NDC and GTIN barcodes.*

FDA Label Image

Container3 (Container3)

Atorvastatin Calcium Tablets, USP 40 mg oral tablets carton label from Dr. Reddy's Laboratories Inc. The label indicates a quantity of 90 tablets and features the product name prominently with dosage strength. It includes a barcode, NDC number 43598-832-90, and regulatory and manufacturing information in smaller print.*

FDA Label Image

Container4 (Container4)

Atorvastatin Calcium Tablets, USP 80 mg tablet bottle label from Dr. Reddy's Laboratories Inc. The label states the product name, strength (80 mg), and quantity (90 tablets). It includes a NDC number 43598-833-90, a barcode, and indicates it is for prescription use only. Additional instructions and manufacturing details are printed in small text.*

FDA Label Image

Figure1 (Figure1)

A line graph comparing the cumulative incidence (%) over 3.5 years between Atorvastatin and placebo groups. The solid line represents Atorvastatin, showing a consistently lower cumulative incidence than the placebo group indicated by the dashed line. The graph includes a hazard ratio (HR) of 0.64 with a confidence interval and p-value.*

FDA Label Image

Figure2 (Figure2)

A chart showing cumulative hazard percentages over a 5-year follow-up period comparing Atorvastatin and placebo for time to first primary endpoint. The graph has two curves: a solid line for Atorvastatin and a dashed line for placebo, with Atorvastatin showing lower cumulative hazard. A hazard ratio (HR) of 0.63 with confidence interval 0.48-0.83 and p-value 0.001 is noted.*

FDA Label Image

Figure3 (Figure3)

A line graph comparing the percentage of subjects experiencing the first major cardiovascular endpoint over five years for Atorvastatin 10 mg and 80 mg. The X-axis represents time in years, and the Y-axis shows the percentage of subjects. Two lines show different risk reductions with a hazard ratio of 0.78.*

FDA Label Image

Structure (Structure)

Chemical structure of Atorvastatin Calcium dihydrate, showing molecular connectivity and arrangement of atoms including phenyl groups and fluorophenyl moiety, as well as calcium and water of hydration components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.